» Articles » PMID: 39064594

Progranulin and Vaspin As Potential Novel Markers in the Etiology of Type 1 Diabetes in Children

Overview
Publisher MDPI
Specialty General Medicine
Date 2024 Jul 27
PMID 39064594
Authors
Affiliations
Soon will be listed here.
Abstract

Diabetes is a significant health problem, prompting the search for new therapeutic strategies. Recently, researchers have focused on identifying novel markers for the progression of this condition. It is well established that adipokines, such as progranulin and vaspin, play crucial roles in regulating lipid and carbohydrate metabolism. : This single-center cross-sectional study aimed to assess serum progranulin and vaspin levels in 80 children diagnosed with type 1 diabetes (T1D) and to examine their correlation with body mass index (BMI), glycated hemoglobin, and lipid profile. The cohort included 40 children newly diagnosed with diabetes, 40 children with long-term diabetes (20 well-controlled and 20 poorly controlled), and 14 non-diabetic children as a control group. Progranulin and vaspin levels were determined using a sandwich enzyme-linked immunosorbent assay. : There were no significant differences in the progranulin and vaspin concentrations in the studied groups ( = 0.246 and = 0.095, respectively). No statistically significant differences were noted in the levels of both adipokines among boys and girls within the T1D, well-controlled T1D, and poorly controlled T1D groups. We did not find any differences in the progranulin and vaspin levels among all children with T1D and healthy controls when divided based on BMI percentiles. A negative correlation was observed between progranulin concentration and the age of children in the T1D, well-controlled T1D, and healthy groups. Furthermore, progranulin correlated negatively with BMI among children with T1D. In contrast, vaspin concentration correlated positively with age among healthy children. : Our study provides novel insights into the status of progranulin and vaspin among pediatric participants with varying levels of type 1 diabetes control. However, further research involving larger patient cohorts and different stages of sexual maturation is warranted.

References
1.
Gulcelik N, Usman A, Gurlek A . Role of adipocytokines in predicting the development of diabetes and its late complications. Endocrine. 2009; 36(3):397-403. DOI: 10.1007/s12020-009-9234-7. View

2.
Jian J, Li G, Hettinghouse A, Liu C . Progranulin: A key player in autoimmune diseases. Cytokine. 2016; 101:48-55. PMC: 5303690. DOI: 10.1016/j.cyto.2016.08.007. View

3.
Yang H, Huang Y, Gai C, Chai G, Lee S . Serum vaspin levels are positively associated with diabetic retinopathy in patients with type 2 diabetes mellitus. J Diabetes Investig. 2020; 12(4):566-573. PMC: 8015830. DOI: 10.1111/jdi.13385. View

4.
Lan Y, Sam N, Cheng M, Pan H, Gao J . Progranulin as a Potential Therapeutic Target in Immune-Mediated Diseases. J Inflamm Res. 2021; 14:6543-6556. PMC: 8655512. DOI: 10.2147/JIR.S339254. View

5.
Youn B, Bang S, Kloting N, Park J, Lee N, Oh J . Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes. 2008; 58(3):627-36. PMC: 2646061. DOI: 10.2337/db08-1147. View